Microporous polysaccharide hemosphere efficacy and safety in primary total knee arthroplasty

Publication date: Available online 6 December 2018Source: Journal of OrthopaedicsAuthor(s): Scott Gleason, David Mehl, William Payne, Steve Parry, Amy Buros SteinAbstractAbsorbable hemostats such as microporous polysaccharide hemospheres (MPH) are used to manage hemostasis and prevent complications in total knee arthroplasty (TKA). We aimed to determine safety and effectiveness of MPH use in TKA. Records were reviewed for blood loss, hematomas, and infections. No differences existed regarding demographics, superficial infections (P = 0.933) or hematomas (P = 0.393). Positive correlation existed between hematoma and superficial infection (P = 0.009). Blood loss was greater in the treatment group (P = 0.014). MPH demonstrated inferior bleeding control and had no effect on complications. Our results suggest application of this agent may be unnecessary.
Source: Journal of Orthopaedics - Category: Orthopaedics Source Type: research
More News: Bleeding | Orthopaedics